Bridgewealth Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$339K Buy
283
+37
+15% +$37.8K 0.06% 95
2026
Q1
$226K Hold
246
0.05% 117
2025
Q4
$264K Buy
+246
New +$235K 0.06% 102
2025
Q1
Sell
-246
Closed -$214K 79
2024
Q4
$214K Buy
246
+16
+7% +$13.2K 0.06% 105
2024
Q3
$204K Buy
+230
New +$207K 0.07% 84
2024
Q2
Sell
-300
Closed -$233K 79
2024
Q1
$233K Buy
+300
New +$214K 0.11% 67

Other funds holding LLY

Bridgewealth Advisory Group's LLY Position: Q2 2026 in Review

Bridgewealth Advisory Group increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $37.8K and bringing the position to 283 shares worth $339K. The position accounts for 0.06% of the portfolio, ranked #95.

Bridgewealth Advisory Group first reported a position in LLY in Q1 2024 and has held it in 6 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bridgewealth Advisory Group held 283 shares of Eli Lilly worth $339K as of Q2 2026.
  • Bridgewealth Advisory Group bought 37 Eli Lilly shares in Q2 2026, an estimated $37.8K.
  • Eli Lilly made up 0.06% of Bridgewealth Advisory Group's portfolio in Q2 2026, its #95 holding.
  • Bridgewealth Advisory Group first reported a position in Eli Lilly in Q1 2024 and has held it in 6 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bridgewealth Advisory Group's 13F filing for Q2 2026, filed 27 Jul 2026.